SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326190-24-000019
Filing Date
2024-05-09
Accepted
2024-05-09 16:05:54
Documents
58
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alt-20240331x10q.htm   iXBRL 10-Q 903825
2 EX-31.1 alt-20240331xex31d1.htm EX-31.1 11934
3 EX-31.2 alt-20240331xex31d2.htm EX-31.2 11777
4 EX-32.1 alt-20240331xex32d1.htm EX-32.1 6754
5 EX-32.2 alt-20240331xex32d2.htm EX-32.2 6884
6 GRAPHIC alt-20240331x10q002.jpg GRAPHIC 16725
  Complete submission text file 0001326190-24-000019.txt   4375971

Data Files

Seq Description Document Type Size
7 EX-101.SCH alt-20240331.xsd EX-101.SCH 31991
8 EX-101.CAL alt-20240331_cal.xml EX-101.CAL 39206
9 EX-101.DEF alt-20240331_def.xml EX-101.DEF 110027
10 EX-101.LAB alt-20240331_lab.xml EX-101.LAB 315410
11 EX-101.PRE alt-20240331_pre.xml EX-101.PRE 210882
62 EXTRACTED XBRL INSTANCE DOCUMENT alt-20240331x10q_htm.xml XML 632714
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 24930463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)